Doctors are cautioning the public against misinterpreting tumor marker blood tests as effective tools for general cancer screening. These tests, while useful in specific medical situations, often lead to false alarms and unnecessary procedures when used for early detection in healthy individuals. Oncologists emphasize that current international guidelines do not recommend routine tumor marker testing for most healthy adults.[indianexpress]
Understanding Tumor Markers
Tumor markers are substances found in blood, urine, or tissue that can indicate the presence of cancer. These markers are typically proteins produced by cancer cells or by the body in response to cancer.Examples include CEA for colorectal cancer, CA-125 for ovarian cancer, AFP for liver cancer, CA 19-9 for pancreatic cancer, and PSA for prostate disease.[cancer+6]
However, experts like Dr. Saneya Pandrowala, a Consultant in GI & HPB Oncosurgery at KIMS Hospitals, Thane, explain that these markers are not cancer-specific."They are far more useful in people who already have a diagnosed cancer, where they help monitor treatment response, detect recurrence or assess disease progression," Dr. Pandrowala said.These tests play a crucial role in tracking how well cancer treatment is working or if cancer has returned after treatment.[indianexpress+3]
Why They Fail as Screening Tools
Despite their importance in cancer management, tumor markers are largely ineffective for general cancer screening. Studies have consistently shown that these markers do not work well for detecting cancer at an early stage in people without symptoms.The main reasons are their lack of specificity and sensitivity.[cancer+4]
A key problem is that many non-cancerous conditions can cause elevated tumor marker levels. Infections, inflammation, liver disease, pancreatitis, endometriosis, and even smoking can all lead to higher-than-normal readings.Fred Hutch gastrointestinal oncologist Dr. Gabriela Chiorean noted that a patient with COVID or a bronchial infection could see their markers "through the roof," mistakenly fearing cancer recurrence.This lack of specificity results in many false positives.[indianexpress+6]
Conversely, tumor markers also suffer from low sensitivity. Many people with early-stage cancers have completely normal tumor marker levels.Some cancers do not produce these markers, or they might not produce enough to be detected until the disease is advanced.This means a normal test result does not guarantee the absence of cancer, leading to dangerous false negatives.[indianexpress+7]
The Risk of False Results
Indiscriminate tumor marker testing can create significant problems for patients. A false positive result can trigger immense anxiety and lead to a cascade of unnecessary and costly follow-up tests, including additional scans and biopsies.This can be financially draining and emotionally taxing. "An unexplained marker rise often leads to more scans, more blood draws, more appointments and weeks of uncertainty," according to The Cancer Strategist.[indianexpress+4]
Furthermore, relying on these tests for screening can give a false sense of security. If a person with early cancer receives a normal tumor marker result, they might delay seeking proper medical evaluation for symptoms, potentially missing a critical window for effective treatment.The National Cancer Institute highlights that studies have generally found these markers do not work well for screening because they often miss the disease or falsely suggest its presence.[oncolink+1]
Dr. Pandrowala stressed that current international guidelines do not support using blood tests as a general cancer-screening tool. This is because they have not been shown to reduce cancer-related deaths in the general population.Tumor markers provide only "one piece of the diagnostic puzzle" and should always be interpreted alongside clinical evaluation, imaging, and other appropriate investigations.[indianexpress+4]
Proper Cancer Screening Methods
Instead of relying on tumor markers for general screening, medical professionals advocate for evidence-based screening methods targeted to specific cancers and eligible individuals. These proven methods have demonstrated their ability to detect cancer early and improve outcomes.[indianexpress]
For example, mammography is recommended for breast cancer screening.Cervical cancer screening involves tests like Pap smears.Colorectal cancer screening typically includes fecal occult blood tests and colonoscopies.For prostate cancer, the Prostate Specific Antigen (PSA) test is sometimes used for screening, but even this marker has concerns regarding false positives and not detecting early-stage disease reliably.[indianexpress+6]
Some high-risk individuals may benefit from selective tumor marker testing as part of a broader surveillance program. This includes people with chronic liver disease, hereditary cancer syndromes, or a strong family history of certain cancers.However, even in these cases, tumor markers are never used in isolation.They are ordered based on clinical judgment, not as part of a routine wellness package.[indianexpress+2]
The Importance of Professional Guidance
The medical community's message is clear: tumor marker tests are valuable tools in cancer care, but they are not a substitute for evidence-based screening or a routine annual test for healthy adults.Patients should discuss their individual risk factors and appropriate screening schedules with their healthcare providers.[indianexpress+1]
Doctors want to learn as much as possible about each person's cancer, and tumor markers are one piece of that information.However, they must be used carefully and in the correct context to avoid unnecessary worry and ineffective interventions.[ascopost+2]
